A vaccine for Shigella developed by scientists at the University of Kansas (KU) and Oklahoma State University (OSU) will go through Phase I clinical trials at a medical center in the Baltimore, MD, area later
Continue Reading Kansas Institute Moves Shigella Vaccine Out for Clinical Trials